Mission Statement, Vision, & Core Values (2026) of Blue Jet Healthcare Limited.

At Blue Jet Healthcare Limited, a global, science-led pharmaceutical company with five decades of expertise, the pursuit of customer delight and uncompromising quality fuels a strategy that spans three specialized verticals-Contrast Media Intermediates, High-Intensity Sweeteners, and Pharma Intermediates & APIs-backed by complex chemistry capabilities and regulatory alignment; the company operates from four manufacturing facilities in Maharashtra and is expanding on a new 102.48-acre site in Andhra Pradesh, supporting a workforce of 500+ employees, serving 350+ customers across more than 30 countries with 50+ commercialized molecules, while its mission of customer-centric quality, vision to be a prominent global player, and core values of quality, integrity, leadership, respect, and sustainability-underscored by the 2025 Excellence in Energy Efficient Unit Award-drive growth through new projects, products, and technology.

Blue Jet Healthcare Limited (BLUEJET.NS) - Intro

• Established strengths: complex chemistry, global regulatory alignment, long-standing partnerships with innovators and generics.
• Operational footprint: four manufacturing sites in Maharashtra (Shahad, Ambernath, Mahad, solvent storage at Morivali) and a greenfield expansion in Andhra Pradesh on a 102.48-acre site.
• Customer & product reach: >350 customers, 50+ commercialized molecules, exports to 30+ countries.

Mission

• Deliver high-quality, reliable pharmaceutical intermediates and APIs through science-driven innovation and stringent regulatory compliance.
• Enable partners (innovators, generics, FMCG) to access critical chemistries with predictable supply chains and scalable manufacturing.
• Operate responsibly-prioritizing safety, energy efficiency, and environmental stewardship while maintaining commercial competitiveness.

Vision

• To be a preferred global partner for complex API/intermediate supply - recognized for technical excellence, regulatory trust, and sustainable manufacturing.
• Scale capabilities across Contrast Media Intermediates, High-Intensity Sweeteners, and Pharma Intermediates & APIs to increase global market share and broaden molecule throughput.
• Leverage the Andhra Pradesh greenfield site to expand capacity, diversify product mix, and support long-term revenue growth.

Core Values

• Scientific Rigor - relentless focus on quality, reproducibility, and process optimization.
• Integrity & Compliance - alignment with international regulatory norms and transparent governance.
• Customer Centricity - reliable supply, technical collaboration, and long-term partnerships.
• Sustainability - energy-efficient operations, emissions control, and resource stewardship.
• Employee Empowerment - skills development across chemistry, manufacturing, quality, and EHS disciplines.

Strategic Pillars & Metrics

• Specialized verticals: Contrast Media Intermediates, High-Intensity Sweeteners, Pharma Intermediates & APIs.
• Capacity expansion: leveraging a 102.48-acre greenfield site to increase tonnage, diversify chemistries and enhance backward integration.
• Sustainability targets: continuous energy-efficiency improvements-recognized with the Excellence in Energy Efficient Unit Award at the 26th CII National Awards in 2025.

Operational & Financial Discipline

• Quality systems and regulatory readiness aimed at accelerating approvals and sustaining supply to multinational partners.
• Commercial focus on diversified revenue streams across three verticals and 350+ customers to reduce single-customer concentration risk.
• Capital allocation prioritizes safe scale-up (greenfield site), energy efficiency retrofits, and process chemistry investments to improve margins and reduce per-unit environmental footprint.

Blue Jet Healthcare Limited (BLUEJET.NS) - Overview

• Customer delight as a KPI: product quality, service responsiveness, after-sales support.
• Quality-first orientation: GMP-compliant processes, batch-level QC, and traceability in manufacturing and distribution.
• Growth through projects and technology: investment in new product development, formulation upgrades and process automation.

• Operational excellence - reducing defects, improving yield and shortening time-to-market for formulations.
• Customer retention - building long-term contracts with distributors, hospitals and institutional buyers.
• Innovation - launching value-added formulations and leveraging contract manufacturing opportunities.

• Geographic expansion - increasing presence in new states and export markets.
• Product portfolio diversification - entering higher-margin therapeutic segments and niche formulations.
• Scale & efficiency - augmenting capacity through brownfield/greenfield projects and process improvements.

• Quality - uncompromising standards in materials, manufacturing and documentation.
• Integrity - ethical sourcing, transparent reporting and regulatory compliance.
• Customer focus - responsiveness, partnership and lifecycle support for products.
• Innovation - continuous improvement in formulations, packaging and processes.
• Safety & sustainability - workplace safety, environmental stewardship and responsible waste management.

Blue Jet Healthcare Limited (BLUEJET.NS) - Mission Statement

• Global ambition: expand export footprint across regulated and semi-regulated markets (APAC, Africa, LATAM, select EU regions).
• Innovation focus: invest in formulation upgrades, cold-chain capabilities, and digital quality systems to ensure regulatory compliance and market readiness.
• Leadership goal: achieve brand recognition in niche therapeutic segments and become a preferred partner for contract manufacturing and private label supply.

• Quality & Compliance - Achieve and maintain GMP certifications for all manufacturing lines and reduce batch rejection rates to <1%.
• Product Pipeline - Launch X-Y new formulations annually (therapeutic and generic niche molecules) to diversify revenue sources.
• Capacity & Technology - Increase manufacturing capacity by 25-40% over a 3-year horizon via greenfield/upgradation projects and automation investments.
• Financial Discipline - Improve EBITDA margins through operational efficiencies and higher-value product mix; aim for double-digit EBITDA margin expansion.

• Patient-centric supply: ensure uninterrupted availability of essential medicines with strong cold-chain logistics where required.
• R&D and formulation excellence: continuous investment in process R&D to reduce cost of goods sold (COGS) and accelerate time-to-market.
• Partnership-driven scale: pursue contract manufacturing agreements, licensing deals, and collaborative exports to access new markets quickly.
• Sustainable operations: adopt waste reduction, energy-efficient processes, and environmentally compliant effluent treatment across facilities.

• Integrity - adherence to ethical manufacturing, transparent reporting, and regulatory compliance.
• Excellence - relentless pursuit of quality in formulations, packaging, and supply chain performance.
• Customer focus - responsiveness to healthcare providers, distributors, and patients; timely delivery and product support.
• Innovation - continuous process and product improvement to meet evolving therapeutic needs.
• Sustainability - commitment to environmentally responsible manufacturing and community health engagement.

• Capacity expansion projects targeting scalable volumes for export contracts and private-label manufacturing.
• Targeted launches in therapeutic niches with high demand and limited competition to capture premium pricing.
• Strengthening regulatory affairs to secure approvals in semi-regulated and regulated markets, reducing time-to-market by compressed approval timelines.
• Operational excellence programs to reduce COGS, improve throughput, and protect margins during expansion.

Blue Jet Healthcare Limited (BLUEJET.NS) - Vision Statement

• Quality - commitment to stringent manufacturing standards, GMP compliance, and continual product improvement.
• Integrity - ethical conduct, transparent disclosure practices, and regulatory adherence across supply chains.
• Leadership - pursuing R&D, technology adoption, and market expansion to set sector benchmarks.
• Respect - fostering diversity, employee wellbeing, and collaborative partnerships with clinicians and communities.
• Sustainability - minimizing environmental footprint, responsible sourcing, and long-term socioeconomic value.

• Quality assurance: expand QA/QC labs, achieve/maintain regulatory certifications (GMP, WHO/GMP for exports).
• Ethical governance: strengthen compliance frameworks, periodic transparency disclosures, and supplier audits.
• Innovation & leadership: allocate R&D/capex to new formulations, biosimilars/OTC portfolio expansion, and digital manufacturing initiatives.
• People & respect: talent development programs, diversity hiring targets, and workplace safety KPIs.
• Sustainability: implement energy efficiency, waste reduction, and water management projects tied to measurable targets and timelines.